Status:
UNKNOWN
Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis
Lead Sponsor:
Ghada zaki
Conditions:
Mucositis Oral
Eligibility:
All Genders
18-89 years
Phase:
PHASE3
Brief Summary
Oral mucositis consequences can range from pain, decreased oral intake, impaired speech and swallowing to adverse events as severe as septicemia, increased hospitalization, and G-tube feeding A wide v...
Detailed Description
The term "mucositis" was introduced to describe inflammation of the oral mucosa induced by radiotherapy, chemotherapy and bone marrow transplantation. At present, oral mucositis is considered to be th...
Eligibility Criteria
Inclusion
- A- Inclusion criteria:
- Patients having clinical signs of chemotherapy-induced or radiotherapy-induced OM (WHO oral mucositis grading scale: Grade II, III and IV)
- Patients over the age of 18 years
- Patients having no history of allergy, allergic rhinitis and asthma
- B- Exclusion criteria:
- Patients allergic to the used treatment
- Patient receiving systemic steroids
- Patients who don't approve to participating in the clinical trial.
Exclusion
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04303312
Start Date
December 1 2021
End Date
March 1 2022
Last Update
August 6 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.